RESULTS OF MOLECULAR ANALYSIS OF SENSITIZATION IN CHILDREN WITH BRONCHIAL ASTHMA LIVING IN THE SYRDARYA REGION

Prospects for the development of pediatric allergology are associated with the design and implementation of technologies for clinical trials involving the active introduction of molecular biomarkers into practice. For the first time, sensitization molecular screening using the ALEX chip was evaluated in children in the Syrdarya region.. Rational treatment and prevention of BA (bronchial asthma) will contribute to the reduction of complications, disability, as well as the reduction of financial and other costs for the patient and the state.